Nexgel (NXGL) EBITDA Margin Growth (1y) (2019 - 2025)
Nexgel (NXGL) EBITDA Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -321.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -658.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -315.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 192.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 563.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -331.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2,844.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 26.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -495.00 |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | 8,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,238.00 |
| Sep 30, 2025 | 209.00 |
| Jun 30, 2025 | 5,114.00 |
| Mar 31, 2025 | 4,111.00 |
| Dec 31, 2024 | 8,501.00 |
| Sep 30, 2024 | 2,332.00 |
| Jun 30, 2024 | -790.00 |
| Mar 31, 2024 | 7,362.00 |
| Dec 31, 2023 | 3,638.00 |
| Sep 30, 2023 | 13,245.00 |
| Jun 30, 2023 | 6,269.00 |
| Mar 31, 2023 | 6,263.00 |
| Dec 31, 2022 | 1,737.00 |
| Sep 30, 2022 | -48.00 |
| Jun 30, 2022 | 463.00 |
| Mar 31, 2022 | -1,029.00 |
| Dec 31, 2021 | 50,289.00 |
| Sep 30, 2021 | 3,898.00 |
| Jun 30, 2021 | 46,079.00 |
| Mar 31, 2021 | 1,733.00 |